Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HLA-A |
| Upstream (Parents) |
|---|
| (<<) CD274 → HLA-A |
| (<<) IRF1 → HLA-A |
| (<<) JAK3 → HLA-A |
| (<<) KIAA1949 → HLA-A |
| (<<) NR3C1 → HLA-A |
| (<<) STAT2 → HLA-A |
| (<<) TRAF1 → HLA-A |
| (<<) UBE2L6 → HLA-A |
| (<<) ZBED2 → HLA-A |
| Downstream (Children) |
|---|
| HLA-A → ADCY3 (>>) |
| HLA-A → CASP5 (>>) |
| HLA-A → EFHD2 (>>) |
| HLA-A → ELF4 (>>) |
| HLA-A → GBP2 (>>) |
| HLA-A → HLA-F (>>) |
| HLA-A → HLA-G (>>) |
| HLA-A → ICAM1 (>>) |
| HLA-A → IGFBP2 (>>) |
| HLA-A → MAP2K1 (>>) |
| HLA-A → MAP3K14 (>>) |
| HLA-A → MESDC1 (>>) |
| HLA-A → NFIL3 (>>) |
| HLA-A → PARP10 (>>) |
| HLA-A → PPP3CA (>>) |
| HLA-A → PTK2B (>>) |
| HLA-A → SOCS1 (>>) |
| HLA-A → TNF (>>) |
| HLA-A → TNFAIP3 (>>) |
| HLA-A → UBQLN1 (>>) |
